jin medical international ltd - ZJYL

ZJYL

Close Chg Chg %
0.22 -0.01 -3.85%

Closed Market

0.21

-0.01 (3.85%)

Volume: 192.81K

Last Updated:

Dec 24, 2025, 1:00 PM EDT

Company Overview: jin medical international ltd - ZJYL

ZJYL Key Data

Open

$0.21

Day Range

0.20 - 0.23

52 Week Range

0.18 - 1.41

Market Cap

$34.44M

Shares Outstanding

156.55M

Public Float

37.82M

Beta

9.33

Rev. Per Employee

N/A

P/E Ratio

18.64

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

140.91K

 

ZJYL Performance

1 Week
 
1.77%
 
1 Month
 
-15.67%
 
3 Months
 
-62.67%
 
1 Year
 
-79.76%
 
5 Years
 
N/A
 

ZJYL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About jin medical international ltd - ZJYL

Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.

ZJYL At a Glance

Jin Medical International Ltd.
33 Lingxiang Road
Changzhou, Jiangsu
Phone 86-519-89607972 Revenue 23.50M
Industry Medical Specialties Net Income 3.68M
Sector Health Technology 2024 Sales Growth 18.569%
Fiscal Year-end 09 / 2025 Employees 269
View SEC Filings

ZJYL Valuation

P/E Current 18.64
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 114.468
Price to Sales Ratio 17.91
Price to Book Ratio 14.614
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 102.159
Enterprise Value to Sales 17.244
Total Debt to Enterprise Value 0.028

ZJYL Efficiency

Revenue/Employee 87,368.067
Income Per Employee 13,665.156
Receivables Turnover 2.678
Total Asset Turnover 0.597

ZJYL Liquidity

Current Ratio 2.496
Quick Ratio 2.081
Cash Ratio 1.56

ZJYL Profitability

Gross Margin 40.434
Operating Margin 15.483
Pretax Margin 17.802
Net Margin 15.641
Return on Assets 9.341
Return on Equity 13.925
Return on Total Capital 9.149
Return on Invested Capital 13.90

ZJYL Capital Structure

Total Debt to Total Equity 39.439
Total Debt to Total Capital 28.284
Total Debt to Total Assets 24.813
Long-Term Debt to Equity 0.334
Long-Term Debt to Total Capital 0.239
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Jin Medical International Ltd - ZJYL

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
20.76M 19.19M 19.82M 23.50M
Sales Growth
+28.22% -7.58% +3.29% +18.57%
Cost of Goods Sold (COGS) incl D&A
14.40M 12.99M 13.04M 14.00M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
341.25K 357.27K 220.95K 328.22K
Depreciation
341.25K 357.27K 220.95K 328.22K
Amortization of Intangibles
- - - -
-
COGS Growth
+34.66% -9.80% +0.34% +7.38%
Gross Income
6.36M 6.20M 6.78M 9.50M
Gross Income Growth
+15.69% -2.56% +9.46% +40.06%
Gross Profit Margin
+30.64% +32.30% +34.23% +40.43%
2021 2022 2023 2024 5-year trend
SG&A Expense
3.73M 4.07M 3.92M 5.86M
Research & Development
1.57M 1.89M 1.54M 1.50M
Other SG&A
2.16M 2.18M 2.37M 4.37M
SGA Growth
+18.64% +9.07% -3.70% +49.69%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
2.63M 2.13M 2.87M 3.64M
Non Operating Income/Expense
258.34K 612.12K 354.67K 544.96K
Non-Operating Interest Income
- 181.61K 182.68K 466.52K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 9.49K
-
Interest Expense Growth
- - - -91.56%
-
Gross Interest Expense
- - - 9.49K
-
Interest Capitalized
- - - -
-
Pretax Income
2.88M 2.74M 3.22M 4.18M
Pretax Income Growth
+22.40% -4.78% +17.48% +29.85%
Pretax Margin
+13.87% +14.29% +16.25% +17.80%
Income Tax
248.64K 36.11K 343.71K 763.88K
Income Tax - Current - Domestic
250.31K 122.13K 254.11K 727.55K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.66K) (86.02K) 89.60K 36.33K
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.63M 2.71M 2.88M 3.42M
Minority Interest Expense
- - - (256.09K)
-
Net Income
2.63M 2.71M 2.88M 3.68M
Net Income Growth
+19.30% +2.84% +6.34% +27.71%
Net Margin Growth
+12.67% +14.10% +14.52% +15.64%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.63M 2.71M 2.88M 3.68M
Preferred Dividends
- - - -
-
Net Income Available to Common
2.63M 2.71M 2.88M 3.68M
EPS (Basic)
0.0164 0.0169 0.0198 0.0235
EPS (Basic) Growth
+18.84% +3.05% +17.16% +18.69%
Basic Shares Outstanding
160.00M 160.00M 145.14M 156.47M
EPS (Diluted)
0.0164 0.0169 0.0198 0.0235
EPS (Diluted) Growth
+18.84% +3.05% +17.16% +18.69%
Diluted Shares Outstanding
160.00M 160.00M 145.14M 156.47M
EBITDA
2.97M 2.49M 3.09M 3.97M
EBITDA Growth
+10.94% -16.31% +24.13% +28.46%
EBITDA Margin
+14.32% +12.96% +15.58% +16.88%

Jin Medical International Ltd in the News